Larry Mathis Financial Planning’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$721K Sell
5,054
-456
-8% -$69.2K 0.61% 34
2026
Q2
$864K Sell
5,510
-65
-1% -$9.7K 0.66% 38
2026
Q1
$852K Sell
5,575
-132
-2% -$20.2K 0.76% 26
2025
Q4
$787K Buy
+5,707
New +$747K 0.69% 36

Other funds holding NVS

Larry Mathis Financial Planning's NVS Position: Q3 2026 in Review

Larry Mathis Financial Planning reduced its Novartis (NVS) stake by 8.3% in Q3 2026, selling an estimated $69.2K and leaving 5,054 shares worth $721K. The position accounts for 0.61% of the portfolio, ranked #34.

Larry Mathis Financial Planning first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $864K in Q2 2026. 1,557 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Larry Mathis Financial Planning held 5,054 shares of Novartis worth $721K as of Q3 2026.
  • Larry Mathis Financial Planning sold 456 Novartis shares in Q3 2026, an estimated $69.2K.
  • Novartis made up 0.61% of Larry Mathis Financial Planning's portfolio in Q3 2026, its #34 holding.
  • Larry Mathis Financial Planning first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
  • Larry Mathis Financial Planning's Novartis position peaked at $864K in Q2 2026.
  • 1,557 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Larry Mathis Financial Planning's 13F filing for Q3 2026, filed 26 Oct 2026.